Complement consumption was more prevalent among the active SLE patients, with 72.2% showing low antigenic C3 levels and 71.5% with low antigenic C4, as compared to 44.2% and 51.4%, respectively, in inactive SLE patients. The gene discussed is C3; the disease is systemic lupus erythematosus.